Sana Dole Karam MD

PubMed

• Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7immunorad conference.
  Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, Desiree Deandreis, Sandra Demaria
  Oncoimmunology. 2025-12-01
• The Use of Virtual Reality for 3D Diagnostic Imaging Review Enhances Understanding and Education of Patients with Cancer.
  Douglas E Holt, Alaina L Carr, Sydneyjane Roberts, Sarah A Milgrom, Elissa Kolva
  International Journal of Radiation Oncology, Biology, Physics. 2025-03-28
• Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.
  Zachary S Morris, Sandra Demaria, Arta M Monjazeb, Silvia C Formenti, Ralph R Weichselbaum
  The Lancet. Oncology. 2025-03-01

Journal Articles

• Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients with Oral Cavity Cancer  
  Ding Ding, Whitney Sumner, David Raben, Mohammad Hararah, Jessica McDermott, Sana D Karam, Julie Goddard, Hilary Somerset, JAMA
• Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer  
  Hilary Somerset, Antonio Jimeno, David Raben, Sana D Karam, Dara L Aisner, Madeleine Kane, Carrie Marshall, Daniel W Bowles, Clinical Cancer Research
• Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers  
  Sana D Karam, Dallin Milner, Hilary Somerset, Antonio Jimeno, David Raben, Clinical Cancer Research